Log In
Print
BCIQ
Print
Print this Print this
 

eritoran (E5564)

  Manage Alerts
Collapse Summary General Information
Company Eisai Co. Ltd.
DescriptionSynthetic lipid A analog that blocks toll-like receptor 4 (TLR4) activation
Molecular Target Toll-like receptor 4 (TLR4)
Mechanism of ActionUndisclosed
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationSepsis
Indication DetailsTreat severe sepsis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today